Haselmeier acquires drug manufacturing license

Solutions provider for self-injection devices Haselmeier has acquired a drug manufacturing license to expand its offering to pharma and biotechnology companies.

The company acquired the license to manufacture pharmaceuticals in December 2018 and now offers assembly, labelling and packaging services.

Haselmeier develops and produces customiSed, unique self-injection systems that are used worldwide to ensure therapeutic efficiency and quality of life in patients.

Going forward Haselmeier will assemble cartridges supplied by customers for the therapies used with the injection pens it manufactures. Alongside packaging and labelling services, the company also includes the manufacture of batches for stability testing as part of its offering.

Konrad Betzler, chief quality officer of Haselmeier: "I am pleased that, after extensive preparatory work and in close coordination with the responsible GMP supervisory authority, we have now received the manufacturing permit".